With 80% ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) boasts of strong institutional backing

4d ago, source:

Key Insights Significantly high institutional ownership implies BioCryst Pharmaceuticals' stock price is sensitive ...

BioCryst to Report First Quarter 2024 Financial Results on May 6

4d ago, source:

RESEARCH TRIANGLE PARK, N.C., April 22, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: BCRX) today announced that the company will report ...

BioCryst Pharmaceuticals gets grant for inhibitors of the complement system for disease treatment

2d ago, source: Pharmaceutical Technology

Discover how BioCryst Pharmaceuticals' patent for complement system inhibitors offers targeted treatment options for diseases like paroxysmal nocturnal hemoglobinuria.

BCRX BioCryst Pharmaceuticals, Inc.

3d ago, source: Seeking Alpha

BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous ...

BioCryst Pharma Stock (NASDAQ:BCRX), Analyst Ratings, Price Targets, Predictions

16d ago, source: Benzinga.com

$4.50 565.93% HC Wainwright & Co.

BioCryst: Brazilian Health Regulatory Agency Approves ORLADEYO - Quick Facts

9d ago, source:

BioCryst Pharmaceuticals, Inc. (BCRX) announced the Brazilian Health Regulatory Agency has granted approval for oral, once-daily ...

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

29d ago, source: Nasdaq

RESEARCH TRIANGLE PARK, N.C., April 03, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors ...

BioCryst: Q4 Earnings Snapshot

2mon ago, source: Times Union

DURHAM, N.C. (AP) — DURHAM, N.C. (AP) — BioCryst Pharmaceuticals Inc. (BCRX) on Monday reported a loss of $61.7 million in its fourth quarter. The Durham, North Carolina-based company said it ...

BioCryst Pharmaceuticals, Inc.: BioCryst Announces Approval of ORLADEYO (berotralstat) by the Brazilian Health Regulatory Agency

9d ago, source:

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted approval ...

BioCryst Pharmaceuticals Inc BCRX

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BioCryst Pharmaceuticals Inc BCRX

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...